Want to join the conversation?
$IDRA expects initiating a Phase 2 clinical trial of IMO-8400 in dermatomyositis in 4Q15. The company may enroll approx. 48 patients in the trial which it expects to conduct at approx. 20 clinical sites. As of Sept. 30, 2015, $IDRA had an accumulated deficit of $488MM and anticipates incurring substantial operating losses in future periods.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!